Aptus Pharma Board to Consider Preferential Equity Allotment on 12th Nov'26
Aptus Pharma Ltd 路 Intimation 路 06 Nov 2026, 5:15 pm
Aptus Pharma Board to Consider Preferential Equity Allotment on 12th Nov'26 Aptus Pharma Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the allotment of equity shares on a preferential basis to proposed allottees. The preferential issue follows shareholder approval obtained at the Annual General Meeting on 14th Sep'26 and receipt of in-principle approval from BSE Limited on 30th Oct'26. The allotment remains subject to the receipt of subscription money and adherence to applicable statutory and regulatory compliances.
Original exchange filing (PDF)
More announcements from Aptus Pharma Ltd
- Outcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations, 2015 路 12 Nov 2026
- Receipt of In-Principle Approval for Preferential Issue 路 31 Oct 2026
- Transcript for Earning Call for the Quarter and Half Year ended on September 30, 2026 路 30 Oct 2026
- Audio recording of the Earnings Call dated October 26, 2026 路 27 Oct 2026
- Intimation of Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 23 Oct 2026
- Intimation of Earnings Call for the quarter and half year ended September 30, 2026 路 26 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... 路 21 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... 路 21 Oct 2026
